Shannon Morris sold $301k of ERAS
Chief Medical Officer at Erasca, Inc.. 20,000 shares at an average of $15.04, traded Mar 4, 2026, filed Mar 6, 2026.
Score components
- +15RoleOfficer
- +14Trade size$301k at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +15.1%, 3m -22.6%, 6m +4.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-095181, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | MOption exercise Common Stock10b5-1 | +20,000 | $1.70 | $34k | 20,000 | Mar 6, 2026 |
| Mar 4, 2026 | SOpen-market sale Common Stock10b5-1 | -20,000 | $15.04 | $301k | 0 | Mar 6, 2026 |
| Mar 4, 2025 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -20,000 | $0.00 | $0 | 515,800 | Mar 6, 2026 |
Related signals
Other insiders at Erasca, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | Erasca, Inc. | Ebun Garner Chief Legal Officer | $1.3M 80,000 shares | -76% | |
| 20Weak | Erasca, Inc. | Ebun Garner General Counsel & Corp. Sec. | $671k 120,000 shares | -83% | |
| 34Weak | ERASbuy Erasca, Inc. | Alexander W. Casdin director | $182k 80,000 shares | +16% | |
| 58Moderate | Erasca, Inc. | Valerie Denise Harding Start director | $18k 10,000 shares | +100% | |
| 86Strong | Erasca, Inc. | Jonathan E Lim Chairman & CEO | $1.7M 1,000,000 shares | +8% | |
| 58Moderate | Erasca, Inc. | Alexander W. Casdin director | $50k 30,000 shares | +6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.